USANA Health Sciences, Inc. Stock News

Breakthrough products and upgrades redefine cellular skincare for radiant, resilient skin SALT LAKE CITY , Sept. 11, 2025 /PRNewswire/ -- USANA (NYSE: USNA), a global leader in cellular nutrition, has unveiled the next evolution of its Celavive skincare brand.

Innovative offerings designed to help people live more vibrant lives SALT LAKE CITY , Sept. 9, 2025 /PRNewswire/ -- USANA, a worldwide leader in the field of cellular nutrition, has announced a fresh set of advancements to its existing Nutritionals product line.

USANA Health Sciences Executive Chairman Shares Insights for September's Self-Improvement Month SALT LAKE CITY , Sept. 2, 2025 /PRNewswire/ -- In celebration of September's Self-Improvement Month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals to take meaningful steps toward personal growth and self-betterment.

Announced at USANA's 2025 Global Convention SALT LAKE CITY , Aug. 22, 2025 /PRNewswire/ -- USANA, a global leader in cellular nutrition, recently announced innovative new products, significant ingredient reformulations and upgrades, and refreshed packaging. The company also introduced its Health Professional Advisory Council, which will transform the way the company delivers the best health pro...

SALT LAKE CITY , Aug. 4, 2025 /PRNewswire/ -- With August marking National Wellness Month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is encouraging people to embrace small daily habits that lead to lasting wellness mentally, physically, and emotionally. "Wellness isn't something you check off a list; it's a rhythm you live," said Guest, author of All the Right Reaso...

USANA Health Sciences is resurfacing as an idea after a strong Q2 report. The direct selling business has continued to struggle with a decline in sales and active customers. A segment turnaround remains uncertain. The previous Hiya acquisition's potential is clearly showing. Operational expansion underlines massive long-term potential for USANA.

USANA Health Sciences, Inc. (NYSE:USNA ) Q2 2025 Earnings Conference Call July 23, 2025 11:00 AM ET Company Participants Andrew Masuda - Director of Investor Relations Brent L. Neidig - Chief Commercial Officer G.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 28, 2025. Key Financial Results Second Quarter 2025 vs. Second Quarter 2024 Net sales of $236 million versus $213 million, representing 11% year-over-year growth. Net earnings of $9.7 million versus $10.4 million. Diluted EPS of $0.52 as compared w...